News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

ICON Wins Informatica Innovation Award For Improved Decisions


5/15/2014 10:23:06 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dublin, Ireland, 15th May, 2014 – ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it was the only CRO to receive the prestigious Informatica Innovation Award for Improved Decisions.

Carefully chosen from more than 5,000 Informatica customers, Innovation Award winners recognise data-centric organisations that have demonstrated leadership in using Informatica solutions to drive innovation and business advantage.

ICON uses Informatica’s Master Data Management (MDM) solution to create a consolidated and reliable view of clinical trial master data, delivering 360-degree insights into study and site related program activities. The solution is a key element of ICON’s information platform, ICONIK, which enables more informed, data-driven decisions regarding the clinical trial process, including the effective use of monitoring resources, patient treatment and safety and site performance. Commenting on the award, Tom O’Leary, ICON’s Chief Information Officer, said: “We are delighted to be recognised for innovation and for helping our customers reduce the time and cost of drug development by enabling them to make more informed decisions. We are achieving market-leading innovation through the combination of our industry expertise and enabling technologies such as ICONIK, Firecrest and ADDPLAN. As a trusted partner to our customers, ICON remains committed to drive further innovation to enhance the drug development process.”

“Each year, Informatica Innovation Awards winners demonstrate the transformative power of clean, safe and connected data in a business or societal context,” said Marge Breya, executive vice president and chief marketing officer, Informatica. “We are privileged to work with such innovative and forward-looking organisations who are not only transforming their businesses, but also changing the world, by putting data at the centre of everything they do. We congratulate them on their achievements and are excited to be playing a part in their successes.”

Thirteen winners across ten categories were announced at the annual Informatica user conference, Informatica World 2014, which took place in Las Vegas this week.

About ICON plc

ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 10,100 employees, operating from 76 locations in 37 countries.

Further information is available at www.iconplc.com

ICON Media Contact
Rebecca Power
Weber Shandwick
Tel: +44 (0) 207 067 0866
rpower@webershandwick.com

This press release contains forward-looking statements. These statements are based on management's current expectations and information currently available, including current economic and industry conditions. These statements are not guarantees of future performance or actual results, and actual results, developments and business decisions may differ from those stated in this press release. The forward-looking statements are subject to future events, risks, uncertainties and other factors that could cause actual results to differ materially from those projected in the statements, including, but not limited to, the ability to enter into new contracts, maintain client relationships, manage the opening of new offices and offering of new services, the integration of new business mergers and acquisitions, as well as economic and global market conditions and other risks and uncertainties detailed from time to time in SEC reports filed by ICON, all of which are difficult to predict and some of which are beyond our control. For these reasons, you should not place undue reliance on these forward-looking statements when making investment decisions. The word "expected" and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are only as of the date they are made and we do not undertake any obligation to update publicly any forward-looking statement, either as a result of new information, future events or otherwise. More information about the risks and uncertainties relating to these forward-looking statements may be found in SEC reports filed by ICON, including its Form 20-F, F-1, S-8 and F-3, which are available on the SEC's website at http://www.sec.gov.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
ICON
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES